• OPEN AN ACCOUNT
Indian Indices
Sensex
78,079.96 113.61
( 0.15%)
Global Indices
Nasdaq
53,790.86 -21.99
(-0.04%)
Dow Jones
7,769.71 20.51
(0.26%)
Hang Seng
68,341.16 817.10
(1.21%)
Nikkei 225
10,757.72 -75.43
(-0.70%)
Forex
USD-INR
95.38 0.10
(0.10%)
EUR-INR
110.06 0.02
(0.01%)
GBP-INR
128.81 0.17
(0.13%)
JPY-INR
0.60 0.00
(-0.21%)

EQUITY - MARKET SCREENER

Shilpa Medicare Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
530549
INE790G01031
138.7336605
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SHILPAMED
100.42
15731.62
EPS(TTM)
Face Value()
Div & Yield %
8.01
1
0.07
 

A-1 consolidated net profit rises 419.05% in the March 2026 quarter
May 12,2026
Net profit of A-1 rose 419.05% to Rs 4.36 crore in the quarter ended March 2026 as against Rs 0.84 crore during the previous quarter ended March 2025. Sales rose 32.52% to Rs 145.27 crore in the quarter ended March 2026 as against Rs 109.62 crore during the previous quarter ended March 2025.

For the full year,net profit rose 64.11% to Rs 5.99 crore in the year ended March 2026 as against Rs 3.65 crore during the previous year ended March 2025. Sales rose 3.45% to Rs 342.91 crore in the year ended March 2026 as against Rs 331.49 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales145.27109.62 33 342.91331.49 3
OPM %4.822.21 -3.542.94 -
PBDT6.572.10 213 10.948.58 28
PBT5.811.18 392 8.074.99 62
NP4.360.84 419 5.993.65 64